Panacea Acquisition Corp.
Status: Closed Deal
U=S+W/3
W=S@11.5
| IPO Proceeds, $M | $143.75M |
|---|---|
| IPO Date | Jul 1, 2020 |
| CEO | Oleg Nodelman |
| Left Lead | Cowen |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | Nuvation Bio |
| Deal Announced | Oct 21, 2020 |
| Deal Size, $M | $2,180.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Feb 9, 2021 |
| Amendment Vote | TBD |
| Closing Date | Feb 10, 2021 |
Formerly PANA
NUVB
NUVB/W
| Price | $9.14 |
|---|---|
| Last closing price | $9.40 |
| H/L, today | $8.89 / $9.44 |
| H/L, 52-week | $0.95 / $2.55 |
| Volume, today | 6,939,846 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.